Abstract
Clinical practice in treating head and neck cancers (HNC) makes use of 18F-fluorodeoxyglucose (FDG) PET/CT, but other tracers are under investigation and may provide additional clinically useful information [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Newbold K, Powell C. PET/CT in radiotherapy planning for head and neck cancer. Front Oncol. 2012;2:189.
Evangelista L, Cervino AR, Chondrogiannis S, Marzola MC, Maffione AM, Colletti PM, Muzzio PC, Rubello D. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview. Nucl Med Commun. 2014;35:123–34.
Rohde M, Dyrvig A-K, Johansen J, Sørensen JA, Gerke O, Nielsen AL, Høilund-Carlsen PF, Godballe C. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2014;50:2271–9.
Caldas-Magalhaes J, Kasperts N, Kooij N, van den Berg CAT, Terhaard CHJ, Raaijmakers CPJ, Philippens MEP. Validation of imaging with pathology in laryngeal cancer: accuracy of the registration methodology. Int J Radiat Oncol Biol Phys. 2012;82:e289–98.
Thiagarajan A, Caria N, Schöder H, Iyer NG, Wolden S, Wong RJ, Sherman E, Fury MG, Lee N. Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. Int J Radiat Oncol Biol Phys. 2012;83:220–7.
Madani I, Duthoy W, Derie C, de Gersem W, Boterberg T, Saerens M, Jacobs F, Grégoire V, Lonneux M, Vakaet L, Vanderstraeten B, Bauters W, Bonte K, Thierens H, de Neve W. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:126–35.
Castadot P, Geets X, Lee JA, Grégoire V. Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort? Radiother Oncol. 2011;101:343–50.
Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014;111:360–5.
Powell C, Schmidt M, Borri M, Koh D-M, Partridge M, Riddell A, Cook G, Bhide SA, Nutting CM, Harrington KJ, Newbold KL. Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol. 2013;106:112–7.
Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, Murthy V, Budrukkar A. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:2083–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Welsh, L., Newbold, K. (2017). Head and Neck Cancers. In: Chua, S. (eds) PET/CT in Radiotherapy Planning . Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-54744-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-54744-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54743-5
Online ISBN: 978-3-319-54744-2
eBook Packages: MedicineMedicine (R0)